Relapsed/Recurrent GBM (Phase 2)
1 clinical trials · Condition
◉ Watch Relapsed/Recurrent GBM (Phase 2)
| Record | Firm | Date |
|---|---|---|
| Phase 1/2 Study of USL311 +/- Lomustine in Advanced Solid Tumors or Relapsed/Recurrent Glioblastoma Multiforme (GBM) (NCT02765165) | Proximagen, LLC | 2016-04-01 |
Track Relapsed/Recurrent GBM (Phase 2) automatically
Every clearance here is in the API, with alerts when new ones post.